Determination of olanzapine in plasma by HPLC and its pharmacokinetics in men

Journal of China Pharmaceutical University

Volumn 33, Issue 5, 2002, Pages 397-400

  Ji, Hui Fang ^a   Xie, Lin ^a   Wang, Jian ^a   Zhang, Yu ^a   Hou, Yuan Yuan ^a   Liu, Xiao Dong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

HPLC UV; Olanzapine; Pharmacokinetics

Indexed keywords

OLANZAPINE; SILICA GEL;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIQUID LIQUID EXTRACTION; MALE; NORMAL HUMAN; ULTRAVIOLET RADIATION;

EID: 29644446549     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Meltzer HY, Fibiger HC, Olanzapine: a new typical antipsychotic drug. Neuropsychopharmacology, 1996, 14:83-85.
2. Fulton B, Goa KL. Olanzapine: a review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. Drugs, 1997, 53(2):281-298.
3. Olesen OV, Linnet K. Determination of olanzapine in serum by high-performance liquid chromatography using ultraviolet detection considering the easy oxidability of the compound and the presence of other psychotropic drugs. J Chromatogr B, 1998, 714:309-315.
4. Callow JT, Barton RD, Clemens M, et al. Analysis of olanzapine in human plasma Utilizing reversed- phase highe- performance liquid chromatography with electrochemical detection. J Chromatogr B, 1995, 668:85-90.
5. Bergstrom RF, Callagham JT, Cerimele BJ, et al. Pharmacokinetic of olanzapine in elderly and young. Pharm Res, 1995, 12 suppl: s358.